Hexa -Tyrosine
CAS No. 6934-38-9
Hexa -Tyrosine( ——— )
Catalog No. M41803 CAS No. 6934-38-9
Hexa-L-Tyrosine is a tyrosine derivative.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 114 | In Stock |
|
| 10MG | 226 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHexa -Tyrosine
-
NoteResearch use only, not for human use.
-
Brief DescriptionHexa-L-Tyrosine is a tyrosine derivative.
-
DescriptionHexa-L-Tyrosine is a tyrosine derivative.
-
In VitroAmino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number6934-38-9
-
Formula Weight997.08
-
Molecular FormulaC54H56N6O13
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 200 mg/mL (200.59 mM; )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Dimiracetam
Dimiracetam (NT-11624) is an orally active anti-neuropathy compound that inhibits hypersensitivity and neurological alterations and may be used in the study of cognitive disorders, depression and neuropathic pain.
-
Acetrizoic acid
Acetrizoic acid is a molecule used as a contrast medium.
-
PACAP (1-38), human,...
PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP), gastrin releasing peptide (GRP), and VIP release. PACAP 1-38 (10-8 M) inhibited gastrin secretion and stimulated somatostatin secretion and motility dose-dependently.
Cart
sales@molnova.com